Resmetirom

CAS No.

920509-32-6

MDL No.

MFCD26142653

C₁₇H₁₂Cl₂N₆O₄

435.20

InChI Key

FDBYIYFVSAHJLY-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

On Request

Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	920509-32-6
Product Name	Resmetirom

Biological Targets

THRB

Associated Conditions

Abnormal circulating lipid concentration·non-alcoholic fatty liver disease·Hypercholesterolemia·familial hypercholesterolemia·non-alcoholic steatohepatitis

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

Resmetirom

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

Resmetirom: First Approval.

Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis.

Resmetirom safe for nonalcoholic fatty liver disease.

Resmetirom proves positive for NASH with liver fibrosis.

Documentation

Similar Products

6-(4-Amino-2,6-dichlorophenoxy)-4-(1-methylethyl)-3(2H)-pyridazinone